| Description |
1 online resource (21 pages) : illustrations |
| Series |
International business online (text) |
|
Thunderbird case series |
| Summary |
Raisio (Finland) is in the final stages of introducing its revolutionary product, Benecol, to the global market. Benecol, when ingested on a daily basis (for example as an additive to margarine), reduces LDL cholesterol levels in the human body by 10-15%. After a successful debut in Finland in the fall of 1996, Raisio has concluded a global marketing agreement with Johnson & Johnson's (US) McNeil Consumer Products Group. The product has now, just prior to introduction in the United States, run into regulatory objections from the Food & Drug Administration (FDA). The question is whether the current strategy is really in the best interests of shareholders, and what the market should do in valuing the prospects for this current hot stock |
| Notes |
Thunderbird case number: A06-99-0004 |
|
Title from resource description page (viewed November 24, 2014) |
| Bibliography |
Includes bibliographical references |
| Notes |
In English |
| Subject |
Functional foods -- Finland -- Raisio -- Case studies
|
|
Corporations -- Investor relations -- Case studies
|
|
Corporations -- Investor relations.
|
|
Functional foods.
|
|
Finland -- Raisio.
|
| Genre/Form |
Case studies.
|
| Form |
Electronic book
|
| Author |
Thunderbird, The American Graduate School of International Management.
|
|
